{"id":"W1875134139","doi":"10.1093/schbul/sbv125","title":"A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes","year":2015,"lang":"en","type":"article","venue":"Schizophrenia Bulletin","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Janssen Pharmaceuticals; St. Jude Medical; Genentech; National Institutes of Health; H. Lundbeck A/S; Gedeon Richter; University of Cambridge; GlaxoSmithKline; FORUM Pharmaceuticals; Les Laboratories Pierre Fabre; Sunovion; Novo Nordisk; Teva Pharmaceutical Industries; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; National Alliance for Research on Schizophrenia and Depression; Amgen; National Institute of Mental Health; Pfizer","keywords":"Aripiprazole; Risperidone; Akathisia; Schizophreniform disorder; Psychology; Schizoaffective disorder; Bipolar I disorder; Schizophrenia (object-oriented programming); Psychiatry; Context (archaeology); Antipsychotic; Extrapyramidal symptoms; Randomized controlled trial; Internal medicine; Partial agonist; Positive and Negative Syndrome Scale; Medicine; Mood; Bipolar disorder; Psychosis; Mania","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005876205,0.0004345913,0.001760743,0.0002208372,0.0001603121,0.00003201793,0.0001440836,0.0001604494,0.0001567665],"category_scores_gemma":[0.0006534467,0.0002501204,0.0003732627,0.0002096081,0.0007729883,0.00003929895,0.0000981846,0.0001635559,0.00002076122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006672638,"about_ca_system_score_gemma":0.0001153421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008129239,"about_ca_topic_score_gemma":0.000967773,"domain_scores_codex":[0.9976075,0.0001661812,0.000877276,0.0004812886,0.000453389,0.0004143888],"domain_scores_gemma":[0.9971219,0.001312212,0.0004078315,0.0005943378,0.0001649432,0.0003987854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.898725,0.001805198,0.04723994,0.0001546772,0.004402812,0.00001960766,0.001295823,0.00002118875,0.0001033883,0.003996714,0.002486721,0.03974887],"study_design_scores_gemma":[0.9412191,0.005180675,0.02455749,0.0002105296,0.003492343,0.00008962368,0.0007315597,0.00426156,0.002537776,0.00356446,0.01368889,0.000466022],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9584709,0.01988365,0.0002211804,0.01581182,0.0001640734,0.004501289,0.0001078446,0.00008811188,0.0007511718],"genre_scores_gemma":[0.9815581,0.0023214,0.0139622,0.00001904922,0.00005118182,0.0005687604,0.00004590754,0.00007413164,0.001399274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04249401,"threshold_uncertainty_score":0.9999951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02747599060070698,"score_gpt":0.3145751239544084,"score_spread":0.2870991333537014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}